Literature DB >> 3574876

Mutagenic potential of a 193-nm excimer laser on fibroblasts in tissue culture.

J Trentacoste, K Thompson, R K Parrish, A Hajek, M R Berman, P Ganjei.   

Abstract

In response to concerns regarding possible DNA damage by far ultraviolet radiation during excimer laser corneal surgery, the mutagenic potential of an argon fluoride excimer laser (193 nm) on BALB/3T3 mouse fibroblasts grown in tissue culture was investigated. The cumulative incidence of anaplastic transformation after subablative radiant exposures from 3.5 mJ/cm2/pulse to 13.4 mJ/cm2/pulse was 3.6% of all cell cultures. The incidence of anaplastic transformation in nonirradiated controls was 4.2%. Transformation after exposure to x-ray radiation (60.9 rad) was 98.8%. The difference between the incidence of transformation of nonirradiated controls or excimer-treated cultures compared with x-ray radiation-treated cells was significant P less than 0.0001 (chi square test). In this standard cell line, 193-nm laser energy does not appear to have substantial mutagenic potential.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574876     DOI: 10.1016/s0161-6420(87)33487-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Development of a system for excimer laser corneal surgery.

Authors:  G O Waring
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Excimer laser "corneal shaping": a new technique for customized trephination in penetrating keratoplasty. First experimental results in rabbits.

Authors:  Klaus Schmitz; Wolfram Schreiber; Wolfgang Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-17       Impact factor: 3.117

3.  Long-term effect of erbium-YAG laser (2.9 microns) on the primate cornea.

Authors:  G A Peyman; C Beyer; J Kuszak; B Khoobehi; M Shahsavari; R Badaro
Journal:  Int Ophthalmol       Date:  1991-07       Impact factor: 2.031

4.  Excimer laser treatment of corneal surface pathology: a laboratory and clinical study.

Authors:  D Gartry; M Kerr Muir; J Marshall
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.